U.S. Supreme Court Won’t Review $124M Penalty For Risperdal Marketing

Mealey's (January 12, 2016, 8:46 AM EST) -- WASHINGTON, D.C. — The U.S. Supreme Court on Jan. 11 declined to review a $124 million consumer law civil penalty imposed by South Carolina against the Ortho-McNeil-Janssen Pharmaceuticals Inc. division of...
To view the full article, register now.